ODDB.org: Open Drug Database

Home - 62502 - 01 - 001

Menveo, Pulver und Lösung (Durchstechflaschen) - Kombipackung(en)

Swissmedic Key	62502001	Registration Holder	GlaxoSmithKline AG
Name	Menveo, Pulver und Lösung (Durchstechflaschen)	Date of registration	30.11.2011
		Introduction of Sequence	30.11.2011
ATC-Classification	Meningococcus A,C,Y,W-135, Tetravalent Purified Polysaccharides Antigen Conjugated (J07AH08)	Revision date
WHO	WHO-DDD	Valid until
Index Therapeuticus (BSV)	08.08.	Show package size	Kombipackung(en)
Index Therapeuticus (Swissmedic)	08.08.	Description
Swissmedic categorie.	B
SL Eintrag	Yes	Indication
Information for professionals	IP	Consumer information
Ex-factory-Price	31.69	Limitation	Yes
Limitation text

Deductible	10 %	Consumer price	50.90
Feedback	FB
GTIN	7680625020015	Medication Code	Impfstoffe
Pharmacode	5360594	Disponibility

Composition

I) Vaccinum conjugatum in praeparatio cryodesiccata: oligosaccharida neisseriae meningitidis A 10 µg conjugatum cum proteinum corynebacteriae diphtheriae CRM 197 16.7-33.3 µg, kalii dihydrogenophosphas corresp. kalium 0.098 mg, saccharum, pro vitro. . II) Vaccini conjugati in solutio: oligosaccharida neisseriae meningitidis C 5 µg conjugatum cum proteinum corynebacteriae diphtheriae CRM 197 7.1-12.5 µg, oligosaccharida neisseriae meningitidis W-135 5 µg conjugatum cum proteinum corynebacteriae diphtheriae CRM 197 3.3-8.3 µg, oligosaccharida neisseriae meningitidis Y 5 µg conjugatum cum proteinum corynebacteriae diphtheriae CRM 197 5.6-10 µg, natrii chloridum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas dihydricus, aqua ad iniectabile q.s. ad solutionem pro 0.5 ml corresp. natrium 1.885 mg.

Packungsbestandteile

Label

Galenic Form

Pulver und Lösung (Durchstechflaschen)

Excipiens

Active Agent	Dose
Oligosaccharida Neisseriae Meningitidis A	10 µg

BAG: Active Agent	Dose
Oligosaccharida Neisseriae Meningitidis A	10 mcg
Oligosaccharida Neisseriae Meningitidis C	5 mcg
Oligosaccharida Neisseriae Meningitidis W135	5 mcg
Oligosaccharida Neisseriae Meningitidis Y	5 mcg
Vaccinum Meningitidis Oligosaccharid. A, C, W135, y Conjugatum Crm

Inactive agents	Dose
Conjugatum cum Proteinum Corynebacteriae Diphtheriae crm 197	16.7-33.3 µg
Potassium Dihydrogenophosphate
Saccharum

Label

Galenic Form

Pulver und Lösung (Durchstechflaschen)

Excipiens

Active Agent	Dose
Oligosaccharida Neisseriae Meningitidis C	5µg / 0.5ml
Oligosaccharida Neisseriae Meningitidis W135	5µg / 0.5ml
Oligosaccharida Neisseriae Meningitidis Y	5µg / 0.5ml

BAG: Active Agent	Dose
Oligosaccharida Neisseriae Meningitidis A	10 mcg
Oligosaccharida Neisseriae Meningitidis C	5 mcg
Oligosaccharida Neisseriae Meningitidis W135	5 mcg
Oligosaccharida Neisseriae Meningitidis Y	5 mcg
Vaccinum Meningitidis Oligosaccharid. A, C, W135, y Conjugatum Crm

Inactive agents	Dose
Conjugatum cum Proteinum Corynebacteriae Diphtheriae crm 197	7.8µg / 0.5ml
Disodium Phosphate Dihydrate
Sodium Chloride
Sodium Dihydrogenophosphate Monohydrate

Source

Data was imported : 08.06.2023 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :

2025	©ywesee GmbH